Delirium associated with bupropion sustained release

Tzu Yun Wang, San Yuan Huang, I. Shin Shiah, Wei Chung Mao, Chih Kang Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Bupropion is a newer antidepressant with the main pharmacological effects of dopamine and norepinephrine reuptake inhibition. The usage of bupropion is relatively safe with minor side effects. In some rare instances, psychosis and delirium may emerge because of its potentiating effects on dopaminergic neurotransmission. Here we presented a case of bupropion SR (300mg/day) related to delirium with concurrent quetiapine (400mg/day) usage. Although there are fewer side effect profiles of bupropion SR, our case revealed acute delirium after administration of a therapeutic dosage of bupropion. Poor cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2B6 (CYP2B6) metabolism and underlying bipolarity may contribute to this adverse effect. Clinicians should be cautioned when prescribing bupropion SR to vulnerable populations.

Original languageEnglish
Pages (from-to)209-211
Number of pages3
JournalJournal of Medical Sciences
Volume29
Issue number4
Publication statusPublished - 2009 Aug 1

Fingerprint

Bupropion
Delirium
Cytochrome P-450 CYP2D6
Vulnerable Populations
Synaptic Transmission
Psychotic Disorders
Antidepressive Agents
Dopamine
Norepinephrine
Pharmacology

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Wang, T. Y., Huang, S. Y., Shiah, I. S., Mao, W. C., & Chen, C. K. (2009). Delirium associated with bupropion sustained release. Journal of Medical Sciences, 29(4), 209-211.
Wang, Tzu Yun ; Huang, San Yuan ; Shiah, I. Shin ; Mao, Wei Chung ; Chen, Chih Kang. / Delirium associated with bupropion sustained release. In: Journal of Medical Sciences. 2009 ; Vol. 29, No. 4. pp. 209-211.
@article{090d6b7703154c52b7f495afff3b6feb,
title = "Delirium associated with bupropion sustained release",
abstract = "Bupropion is a newer antidepressant with the main pharmacological effects of dopamine and norepinephrine reuptake inhibition. The usage of bupropion is relatively safe with minor side effects. In some rare instances, psychosis and delirium may emerge because of its potentiating effects on dopaminergic neurotransmission. Here we presented a case of bupropion SR (300mg/day) related to delirium with concurrent quetiapine (400mg/day) usage. Although there are fewer side effect profiles of bupropion SR, our case revealed acute delirium after administration of a therapeutic dosage of bupropion. Poor cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2B6 (CYP2B6) metabolism and underlying bipolarity may contribute to this adverse effect. Clinicians should be cautioned when prescribing bupropion SR to vulnerable populations.",
author = "Wang, {Tzu Yun} and Huang, {San Yuan} and Shiah, {I. Shin} and Mao, {Wei Chung} and Chen, {Chih Kang}",
year = "2009",
month = "8",
day = "1",
language = "English",
volume = "29",
pages = "209--211",
journal = "Journal of Medical Sciences",
issn = "1011-4564",
publisher = "National Defense Medical Center",
number = "4",

}

Wang, TY, Huang, SY, Shiah, IS, Mao, WC & Chen, CK 2009, 'Delirium associated with bupropion sustained release', Journal of Medical Sciences, vol. 29, no. 4, pp. 209-211.

Delirium associated with bupropion sustained release. / Wang, Tzu Yun; Huang, San Yuan; Shiah, I. Shin; Mao, Wei Chung; Chen, Chih Kang.

In: Journal of Medical Sciences, Vol. 29, No. 4, 01.08.2009, p. 209-211.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Delirium associated with bupropion sustained release

AU - Wang, Tzu Yun

AU - Huang, San Yuan

AU - Shiah, I. Shin

AU - Mao, Wei Chung

AU - Chen, Chih Kang

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Bupropion is a newer antidepressant with the main pharmacological effects of dopamine and norepinephrine reuptake inhibition. The usage of bupropion is relatively safe with minor side effects. In some rare instances, psychosis and delirium may emerge because of its potentiating effects on dopaminergic neurotransmission. Here we presented a case of bupropion SR (300mg/day) related to delirium with concurrent quetiapine (400mg/day) usage. Although there are fewer side effect profiles of bupropion SR, our case revealed acute delirium after administration of a therapeutic dosage of bupropion. Poor cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2B6 (CYP2B6) metabolism and underlying bipolarity may contribute to this adverse effect. Clinicians should be cautioned when prescribing bupropion SR to vulnerable populations.

AB - Bupropion is a newer antidepressant with the main pharmacological effects of dopamine and norepinephrine reuptake inhibition. The usage of bupropion is relatively safe with minor side effects. In some rare instances, psychosis and delirium may emerge because of its potentiating effects on dopaminergic neurotransmission. Here we presented a case of bupropion SR (300mg/day) related to delirium with concurrent quetiapine (400mg/day) usage. Although there are fewer side effect profiles of bupropion SR, our case revealed acute delirium after administration of a therapeutic dosage of bupropion. Poor cytochrome P450 2D6 (CYP2D6) and cytochrome P450 2B6 (CYP2B6) metabolism and underlying bipolarity may contribute to this adverse effect. Clinicians should be cautioned when prescribing bupropion SR to vulnerable populations.

UR - http://www.scopus.com/inward/record.url?scp=69549104714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69549104714&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:69549104714

VL - 29

SP - 209

EP - 211

JO - Journal of Medical Sciences

JF - Journal of Medical Sciences

SN - 1011-4564

IS - 4

ER -

Wang TY, Huang SY, Shiah IS, Mao WC, Chen CK. Delirium associated with bupropion sustained release. Journal of Medical Sciences. 2009 Aug 1;29(4):209-211.